Am J Transplant, Volume 22, Suppl 3 Archives - Page 53 of 190 - ATC Abstracts

2022 American Transplant Congress
Long-Term Implication of Kidney Injury Prior to Liver Transplantation for Acute Liver Failure
M. R. Cloonan¹, D. J. Cloonan², S. Westphal³, L. A. Dageforde¹, S. Merani¹
¹Division of Transplant, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, ²Division of Transplant Surgery, Massachusetts General Hospital, Boston, MA, ³University of Nebraska Medical Center, Omaha, NE
*Purpose: Acute liver failure (ALF) is a heterogeneous disease process that often includes acute kidney injury. Long-term sequelae of kidney impairment in patients with ALF…
2022 American Transplant Congress
Analysis of Antibiotic Resistance and Risk Level of Preservation Fluid Microorganisms in Kidney Transplant Recipients
J. Li¹, X. Su¹, J. Han², Y. Huang², W. Wu¹, M. Wei², S. Yuan², C. Wu¹, J. Li¹, L. Liu¹, C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Sun Yat-sen University, Guangzhou, China
*Purpose: As a solution for preserving kidney during procurement and transportation, preservation fluid (PF) is the main method to detect donor-derived infection. But there are…
2022 American Transplant Congress
Impact of Removing DSA and OPTN Region from Pancreas Allocation
S. E. Booker¹, A. Robinson¹, K. Gauntt¹, J. White¹, S. Niederhaus², O. Olaitan³, R. Forbes⁴
¹UNOS, Richmond, VA, ²University of Maryland School of Medicine, Baltimore, MD, ³Rush University Medical Center, Chicago, IL, ⁴Vanderbilt University Medical Center, Nashville, TN
*Purpose: Donation Service Area (DSA) and OPTN Region were removed from pancreas allocation on 3/15/21 and replaced with a 250 nautical mile (NM) fixed circle…
2022 American Transplant Congress
Direct Oral Anticoagulants versus Warfarin in Adult Heart Transplant Recipients
L. Shitanishi, A. Fan, T. Khuu, R. Ardehali
University of California Los Angeles, Los Angeles, CA
*Purpose: Direct oral anticoagulants (DOACs) have recently transformed the field of anticoagulation, offering more predictable pharmacokinetic and pharmacodynamic characteristics when compared to traditional warfarin therapy.…
2022 American Transplant Congress
De Novo Donor-Specific Antibody Development in Heart Transplant Recipients Following COVID-19 Vaccination
M. Cheng¹, O. Behbahani-Nejad¹, D. Gupta²
¹Internal Medicine, Emory University School of Medicine, Atlanta, GA, ²Internal Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA
*Purpose: To determine the incidence of de novo donor-specific antibodies (DSAs) in recipients of orthotopic heart transplants (OHT) who received an mRNA vaccine against SARS-CoV-2.*Methods:…
2022 American Transplant Congress
Biological Functions of Circulating miRNAs in Patients with Chronic Pancreatitis Undergoing Total Pancreatectomy with Islet Autotransplantation
S. Vasu¹, C. Darden², Y. Liu³, M. Lawrence⁴, B. Naziruddin¹
¹Baylor University Medical Ctr, Dallas, TX, ²Baylor University, Waco, TX, ³-Baylor University Medical Center, Dallas, TX, ⁴Baylor University Medical Center, Dallas, TX
*Purpose: Our previous reports showed that in patients with Chronic Pancreatitis (CP), specific microRNAs (miRNA) were elevated in circulation before, during islet infusion and after…
2022 American Transplant Congress
Meld 3.0 for Liver Allocation: Results From the Liver Simulated Allocation Model
A. Kwong¹, T. Weaver², D. Schladt², A. Wey², K. Audette², S. Biggins³, J. Snyder², A. Israni², J. Lake⁴, W. Kim¹
¹Stanford University, Stanford, CA, ²Hennepin Healthcare Research Institute, Minneapolis, MN, ³University of Washington, Seattle, WA, ⁴University of Minnesota, Minneapolis, MN
*Purpose: Priority on the US liver transplant waitlist is determined by the model for end-stage liver disease (MELD), a score composed of serum bilirubin, creatinine,…
2022 American Transplant Congress
Very Low Frequency of Pathological Findings in One-Year Protocol Biopsies of Low-Risk Kidney Transplant Recipients – Results from the Nordic Protocol Biopsy Study
I. Helanterä¹, C. Dörje², F. Ortiz³, A. Varberg Reisæter², C. Hammarstrøm², J. Lauronen⁴, A. Räisänen-Sokolowski⁵, A. J. Haugen⁶, M. Lempinen¹, A. Åsberg², G. Mjøen²
¹Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland, ²Department of Transplant Medicine, Oslo University Hospital, Oslo, Norway, ³Nephrology, Helsinki University Hospital, Helsinki, Finland, ⁴Histocompatibility Laboratory, Finnish Red Cross Blood Service, Helsinki, Finland, ⁵Department of Pathology, Helsinki University Hospital, Helsinki, Finland, ⁶Medical Department, Bærum Hospital, Bærum, Norway
*Purpose: The clinical usefulness of kidney graft protocol biopsies have been debated. We studied the frequency of borderline and T-cell-mediated rejection (TCMR) in one-year protocol…
2022 American Transplant Congress
The Acuity Circle Allocation Policy is Associated with Worse Graft Survival After Liver Transplant with Donation After Circulatory Death Donors in Low-MELD Centers
T. Kitajima¹, T. Ivanics², D. Moonka¹, M. Shamaa¹, A. Mohamed³, S. Shimada¹, K. Collins⁴, M. Rizzari¹, A. Yoshida¹, M. Abouljoud⁴, S. Nagai¹
¹Henry Ford Hospital, Detroit, MI, ²Surgery, Henry Ford Hospital, Detroit, MI, ³Department of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, ⁴Henry Ford Transplant Institute, Detroit, MI
*Purpose: Liver allocation in the United States was updated in February of 2020, with introduction of the acuity circle (AC) model. However, the effect of…
2022 American Transplant Congress
CoVID-19 Vaccine Efficacy in Heart Transplant Recipients, a Single Center Experience
M. Yu¹, S. B. Sharmin², C. Joyce³, Z. Pieters¹, S. DeSirkar¹, M. Thomas¹, S. Kim¹, E. Bruno¹, M. Liebo¹, A. Heroux⁴, N. Clark¹, G. Reid¹, S. Uprichard²
¹Loyola University Medical Center, Maywood, IL, ²Microbiology and Immunology, Loyola University Chicago, Chicago, IL, ³Department of Public Health Sciences, Loyola University Chicago, Chicago, IL, ⁴Loyola Univ Medical Ctr, Maywood, IL
*Purpose: Transplant recipients have worse CoVID-19 survival compared to the general population, and thus are recommended to be vaccinated and boosted. Determinants of vaccination efficacy…